63A-32778-30598
4 vaccinations
3 coded responses
25 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 223 / VA
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
JFX-84167-72755
Child or adolescent in my care · Female · 2022-06-29
Timeline
-
2021-03-26
Registered in v-safe
-
2021-03-26
Dose 1 — Pfizer-BioNTech
- 2021-03-26
-
2021-03-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
-
2021-04-09
Survey response — day 14, dose 1MedDRA: Nasopharyngitis — Feeling: FairFree text: Feeling cold symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Dose 2 — Pfizer-BioNTech
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-05-03
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-07-19
-
2021-10-16
Survey response — 6 months, dose 2MedDRA: Sinusitis — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-16
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-06
Dose 3 — Moderna
- 2021-11-16
- 2022-04-19
-
2022-09-30
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-17
- 2022-10-26
- 2022-10-28
-
2022-11-04
Survey response — day 35, dose 4MedDRA: Nasopharyngitis — Feeling: FairFree text: ColdMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-17 | Pfizer-BioNTech | |
| 3 | 2021-11-06 | Moderna | No |
| 4 | 2022-09-30 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-16 | Unsuccessful |
Free text
Release 7 — day 14, dose 1
Symptoms: Feeling cold symptoms
Release 10 — 6 months, dose 2
Symptoms: Sinus infection
Release 12 — day 35, dose 4
Symptoms: Cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release